CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Pharma
Original article

Novo Nordisk A/S – Share repurchase programme

Neutral
AI Analysis

Summary

Novo Nordisk announced continuation of its share repurchase programme initiated on 6 May 2026, with a total authorization of DKK 15 billion to be executed over a 12-month period beginning 4 February 2026.

Importance:2/10
Sentiment:
0.00
share repurchasecapital allocationbuyback programme
Related Companies

Read the original article

Published by GlobeNewswire Pharma on October 5, 2026 12:32 PM

Read Original